Switching treatment from innovator etanercept (Enbrel) to etanercept biosimilar (Benepali) in patients with a rheumatic disease in daily clinical care.

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2016
This article has no abstract
Epistemonikos ID: 5d2f8179c0e28681e3dd8064991df94772c99caa
First added on: Apr 16, 2025